Market Place
Sourcing Support
Amphastar to Present at Jefferies London Healthcare Conference
13 Nov 2024 //
ACCESSWIRE
Amphastar Pharmaceuticals Reports Q3 2024 Financial Results
06 Nov 2024 //
ACCESSWIRE
Amphastar Pharmaceuticals to Release Q3 Earnings on Nov 6, 2024
29 Oct 2024 //
ACCESSWIRE
Amphastar To Present At 2024 Wells Fargo Healthcare Conference
28 Aug 2024 //
ACCESSWIRE
Amphastar Pharmaceuticals Reports Q2 2024 Financial Results
07 Aug 2024 //
ACCESSWIRE
Amphastar To Release Q2 Earnings On August 7
31 Jul 2024 //
ACCESSWIRE
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
04 Jun 2024 //
ACCESSWIRE
Amphastar To Present At Jefferies Healthcare Conference
03 Jun 2024 //
ACCESSWIRE
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
22 May 2024 //
ACCESSWIRE
Amphastar At BofA Healthcare Conference 2024
09 May 2024 //
ACCESSWIRE
Amphastar Reports Q1 2024 Financial Results
08 May 2024 //
ACCESSWIRE
Amphastar To Release Q1 Earnings, Host Call On May 8
30 Apr 2024 //
ACCESSWIRE
Amphastar to Present at the 23rd Annual Needham Virtual Healthcare Conference
01 Apr 2024 //
ACCESSWIRE
Amphastar to Present at the Barclays 26th Annual Global Healthcare Conference
06 Mar 2024 //
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results
28 Feb 2024 //
ACCESSWIRE
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings
20 Feb 2024 //
ACCESSWIRE
Amphastar to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
ACCESSWIRE
Amphastar to Present at the Piper Sandler 35th Annual Healthcare Conference
20 Nov 2023 //
ACCESSWIRE
Amphastar Pharma to Present at the Jefferies London Healthcare Conference
09 Nov 2023 //
ACCESSWIRE
Amphastar Reports Financial Results for Three Months Ended September 30, 2023
08 Nov 2023 //
ACCESSWIRE
Amphastar to Release Third Quarter Earnings and Hold Conference Call
01 Nov 2023 //
ACCESSWIRE
Amphastar Announces Pricing of Offering of $300.0M of Convertible Senior Notes
13 Sep 2023 //
PRESS RELEASE
Amphastar Announces Private Offering of $300.0M of Convertible Senior Notes
11 Sep 2023 //
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference
31 Aug 2023 //
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months
08 Aug 2023 //
PRESS RELEASE
Amphastar Pharmaceuticals to Release Second Quarter Earnings
02 Aug 2023 //
ACCESSWIRE
Amphastar Pharmaceuticals (AMPH) Gains As Market Dips: What You Should Know
21 Jul 2023 //
YAHOO FINANCE
Amphastar Pharma: A Company Growing Quickly As Acquisitions Likely Fuel Growth
12 Jul 2023 //
SEEKING ALPHA
Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly
30 Jun 2023 //
ACCESSWIRE
Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?
23 Jun 2023 //
FINANCIAL EXPRESS
Is Amphastar Latest Stock Performance A Reflection Of Its Financial Health?
17 Jun 2023 //
FINANCIAL EXPRESS
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
01 Jun 2023 //
FINANCE YAHOO
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
31 May 2023 //
ACCESSWIRE
Amphastar Pharmaceuticals Reports FYR for the Three Months Ended March 31, 2023
09 May 2023 //
ACCESSWIRE
Amphastar to Release First Quarter Earnings and Hold Conference Call
03 May 2023 //
PRESS RELEASE
Eli Lilly to sell low blood sugar drug to Amphastar for around $1 billion
25 Apr 2023 //
REUTERS
Amphastar Pharma Business Update and Hold Conference Call on April 24th, 2023
24 Apr 2023 //
ACCESSWIRE
Amphastar to Present at 22nd Annual Needham Virtual Healthcare Conference
12 Apr 2023 //
ACCESSWIRE
Amphastar Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg
08 Mar 2023 //
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months
28 Feb 2023 //
ACCESSWIRE
Amphastar to Release Q4 Earnings and Hold Conference on February 28, 2023
22 Feb 2023 //
ACCESSWIRE
Amphastar to Present at the Piper Sandler 34th Annual Healthcare Conference
22 Nov 2022 //
ACCESSWIRE
Amphastar to Present at the 2022 Jefferies London Healthcare Conference
10 Nov 2022 //
ACCESSWIRE
Amphastar Reports Financial Results for the Three Months Ended Sep 30, 2022
07 Nov 2022 //
ACCESSWIRE
Amphastar Pharmaceuticals to Release Third Quarter Earnings
28 Oct 2022 //
ACCESSWIRE
Jefferies Financial Group has initiated coverage of Amphastar Pharmaceuticals
21 Oct 2022 //
BESTSTOCKS
Amphastar Pharmaceuticals to Present at the Wells Fargo 2022
02 Sep 2022 //
ACCESSWIRE
Amphastar Pharma Receives FDA Approval for Epinephrine Pre-Filled Syringes
16 Aug 2022 //
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for 3 Months
08 Aug 2022 //
ACCESSWIRE
Amphastar Pharma to Release Second Quarter Earnings
01 Aug 2022 //
ACCESSWIRE
Amphastar Receives FDA Approval for Vasopressin
19 Jul 2022 //
BIOSPACE
Amphastar Pharma Generic Vasopressin Receives Approval in the U.S.
18 Jul 2022 //
FDA
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
06 Jun 2022 //
PRESS RELEASE
Amphastar Pharma Reports Financial Results for 3 Months Ended March 31, 2022
09 May 2022 //
ACCESSWIRE
Amphastar Pharma to Release Q1 Earnings and Hold Conference Call on May 9, 2022
02 May 2022 //
ACCESSWIRE
Amphastar Receives FDA Approval for Ganirelix Acetate Injection
08 Apr 2022 //
ACCESSWIRE
Amphastar Pharma to Present at 21st Annual Needham Virtual Healthcare Conference
06 Apr 2022 //
ACCESSWIRE
Amphastar Pharma Reports Financial Results for 3 Months and FY 2021
10 Mar 2022 //
PRESS RELEASE
